Destiny Pharma (DEST) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsHeadlinesInsider TradesBuy This Stock Destiny Pharma (LON:DEST) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage25.94%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)£3,100.00Number OfInsiders Selling(Last 12 Months)0 Get DEST Insider Trade Alerts Want to know when executives and insiders are buying or selling Destiny Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DEST Insider Buying and Selling by Quarter Destiny Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/2/2024Nigel RuddInsiderBuy1,240,000GBX 0.25£3,100 (Data available from 1/1/2013 forward) DEST Insider Trading Activity - Frequently Asked Questions Who is on Destiny Pharma's Insider Roster? The list of insiders at Destiny Pharma includes Nick Rodgers, and Nigel Rudd. Learn more on insiders at DEST. What percentage of Destiny Pharma stock is owned by insiders? 25.94% of Destiny Pharma stock is owned by insiders. Learn more on DEST's insider holdings. Which Destiny Pharma insiders have been buying company stock? The following insiders have purchased DEST shares in the last 24 months: Nick Rodgers (£15,337.87), and Nigel Rudd (£3,100). How much insider buying is happening at Destiny Pharma? Insiders have purchased a total of 1,289,477 DEST shares in the last 24 months for a total of £18,437.87 bought. Destiny Pharma Key ExecutivesDr. William Guy Love (Age 62)Founder, Chief Scientific Officer & Director Compensation: $265kMr. Shaun Claydon ACA (Age 56)CFO, Company Secretary & Director Compensation: $286kDr. Debra Barker M.D. (Age 62)MSc., Interim CMO & Senior Independent Director Compensation: $41kMr. Christopher John Tovey BSc (Age 59)CEO & Director More Insider Trading Tools from MarketBeat Related Companies IXI Insider Trading OBD Insider Trading FAB Insider Trading ROQ Insider Trading ONC Insider Trading OCTP Insider Trading GNS Insider Trading ONT Insider Trading OXB Insider Trading BVXP Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish Outlook This page (LON:DEST) was last updated on 5/18/2025 by MarketBeat.com Staff From Our PartnersWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Destiny Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Destiny Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DEST Stock Free DEST Stock Alerts